53 search results for: asthma

Airway Hyperresponsiveness In <b>Asthma</b> Is Mainly Driven By  Components Of Type 2 Inflammation
Pulmonology
Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation
interactivity

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

View more
Airway Hyperresponsiveness In <b>Asthma</b> Is Mainly Driven By Components Of Type 2 Inflammation
Pulmonology
Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation
interactivity

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

View more
The Burden in Patients with CRSwNP and Coexisting <b>Asthma</b>
Pulmonology
The Burden in Patients with CRSwNP and Coexisting Asthma
expert video

This video supports improved clinical awareness and encourages comprehensive care strategies for patients living with both CRSwNP and asthma.

View more
Screen depicting a mucus plug in the airways
Pulmonology
A view into the Airway: The Pathophysiology and Clinical Relevance of Mucus Plugs in Asthma
videoanimation

Explore the role of type 2 inflammation in the production of mucus plugs in asthma and the effects these plugs can have on patients.

View more
Role of Type 2 Cytokines in <b>Asthma</b> and COPD
Type 2 Inflammation
Role of Type 2 Cytokines in Asthma and COPD
expert video

Dr Mario Castro explains how type 2 cytokines play a crucial role in airway remodeling and inflammation in asthma and COPD, impacting patient outcomes.

View more
Mucus Plugging Is a Key Component of Remodeling in <b>Asthma</b>, Leading to Fixed Airway Obstruction
Pulmonology
Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction
Infographic

Learn about the role of type 2 inflammation in the burden and pathophysiology of mucus plugging in severe asthma

View more
ERS 2025 | Type 2 Severe <b>Asthma</b> "Unplugged": Reducing Mucus to Improve Long-term Patient Outcomes
Pulmonology
ERS 2025 | Type 2 Severe Asthma "Unplugged": Reducing Mucus to Improve Long-term Patient Outcomes
videoanimation

Join leading pulmonologists Drs. Njira Lugogo, Simon Couillard, and Mario Castro, as they explore the role of type 2 inflammation in the pathogenesis of mucus plugging in the airways, the burden of excess mucus in patients with moderate-to-severe asthma, and how reducing airway mucus may lead to improved long-term patient outcomes.

View more
CRSwNP at Center Stage: Impact of Biologics in Patients with Co-existing Type 2 <b>Asthma</b>
Pulmonology
CRSwNP at Center Stage: Impact of Biologics in Patients with Co-existing Type 2 Asthma
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Philippe Gevaert explains how biologic options for uncontrolled CRSwNP are increasing, and phase 3 studies of approved biologics show improved outcomes and decreased SCS use/surgery in patients with CRSwNP. Additionally, he explains how biologics targeting type 2 inflammatory pathophysiology potentially improve outcomes for eligible patients with co-existing CRSwNP and asthma.

View more
Why Is It Important to Assess Lung Function in Pediatric <b>Asthma</b>?
Pulmonology
Why Is It Important to Assess Lung Function in Pediatric Asthma?
interactivity

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.

View more
How Type 2 Inflammation Drives Eosinophils in <b>Asthma</b>
Pulmonology
How Type 2 Inflammation Drives Eosinophils in Asthma
videoanimation

Explore how type 2 inflammation drives the production of eosinophils in severe asthma.

View more
Pathways Driving Chronic Airway Remodeling in <b>Asthma</b>
Pulmonology
Pathways Driving Chronic Airway Remodeling in Asthma
videoanimation

See how type 2 inflammation underlies remodeling processes in asthma.

View more
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for <b>Asthma</b> Patients
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more